Public Sector Pension investment Board Sells 1,300 Shares of Heska Corporation (HSKA)

Public Sector Pension investment Board cut its position in Heska Corporation (NASDAQ:HSKA) by 28.9% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,200 shares of the medical research company’s stock after selling 1,300 shares during the quarter. Public Sector Pension investment Board’s holdings in Heska Corporation were worth $327,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Neuberger Berman Group LLC boosted its stake in Heska Corporation by 1.0% in the 2nd quarter. Neuberger Berman Group LLC now owns 449,574 shares of the medical research company’s stock valued at $45,888,000 after purchasing an additional 4,329 shares during the period. Vanguard Group Inc. boosted its stake in Heska Corporation by 47.0% in the 1st quarter. Vanguard Group Inc. now owns 350,609 shares of the medical research company’s stock valued at $36,807,000 after purchasing an additional 112,115 shares during the period. Russell Investments Group Ltd. boosted its stake in Heska Corporation by 18.1% in the 2nd quarter. Russell Investments Group Ltd. now owns 225,388 shares of the medical research company’s stock valued at $23,005,000 after purchasing an additional 34,594 shares during the period. Bank of New York Mellon Corp boosted its stake in Heska Corporation by 29.6% in the 1st quarter. Bank of New York Mellon Corp now owns 202,552 shares of the medical research company’s stock valued at $21,264,000 after purchasing an additional 46,231 shares during the period. Finally, State Street Corp boosted its stake in Heska Corporation by 12.6% in the 1st quarter. State Street Corp now owns 173,917 shares of the medical research company’s stock valued at $18,251,000 after purchasing an additional 19,408 shares during the period. Institutional investors and hedge funds own 81.36% of the company’s stock.

Several analysts recently issued reports on HSKA shares. Aegis boosted their price target on Heska Corporation from $114.50 to $129.50 and gave the company a “buy” rating in a research note on Tuesday, August 1st. BidaskClub downgraded Heska Corporation from a “buy” rating to a “hold” rating in a research note on Sunday, July 16th. Zacks Investment Research upgraded Heska Corporation from a “hold” rating to a “buy” rating and set a $109.00 price target for the company in a research note on Friday, August 4th. B. Riley restated a “neutral” rating and issued a $85.00 price target on shares of Heska Corporation in a research note on Friday, July 28th. Finally, Benchmark Co. restated a “buy” rating and issued a $120.00 price target (up from $106.00) on shares of Heska Corporation in a research note on Wednesday, August 9th. Five analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $106.83.

Shares of Heska Corporation (NASDAQ:HSKA) opened at 97.12 on Friday. The company has a market capitalization of $701.79 million, a P/E ratio of 49.50 and a beta of 0.84. The stock’s 50 day moving average price is $94.48 and its 200-day moving average price is $98.34. Heska Corporation has a 52-week low of $46.51 and a 52-week high of $115.00.

Heska Corporation (NASDAQ:HSKA) last posted its quarterly earnings results on Thursday, August 3rd. The medical research company reported $0.44 EPS for the quarter, topping the Zacks’ consensus estimate of $0.37 by $0.07. Heska Corporation had a return on equity of 15.87% and a net margin of 10.70%. The firm had revenue of $34.30 million during the quarter, compared to analyst estimates of $33.35 million. During the same period last year, the company earned $0.35 earnings per share. The business’s revenue for the quarter was up 14.3% on a year-over-year basis. On average, equities analysts expect that Heska Corporation will post $2.04 earnings per share for the current year.

In other news, EVP Nancy Wisnewski sold 825 shares of the firm’s stock in a transaction on Thursday, August 31st. The stock was sold at an average price of $102.21, for a total value of $84,323.25. Following the completion of the transaction, the executive vice president now directly owns 38,114 shares of the company’s stock, valued at $3,895,631.94. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO John Mcmahon sold 2,608 shares of the firm’s stock in a transaction on Wednesday, August 30th. The stock was sold at an average price of $101.17, for a total value of $263,851.36. Following the completion of the transaction, the chief financial officer now directly owns 193 shares of the company’s stock, valued at $19,525.81. The disclosure for this sale can be found here. 14.70% of the stock is owned by company insiders.

ILLEGAL ACTIVITY WARNING: “Public Sector Pension investment Board Sells 1,300 Shares of Heska Corporation (HSKA)” was originally published by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this piece on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this piece can be read at https://sportsperspectives.com/2017/10/13/public-sector-pension-investment-board-sells-1300-shares-of-heska-corporation-hska.html.

Heska Corporation Company Profile

Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products.

Want to see what other hedge funds are holding HSKA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Heska Corporation (NASDAQ:HSKA).

Institutional Ownership by Quarter for Heska Corporation (NASDAQ:HSKA)

Receive News & Ratings for Heska Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply